Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pharmacogenetic Study × Abiraterone Acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 70 Neoplasm Metastasis 8 Metastatic Castration Resistant Prostate Cancer 4 Breast Neoplasms 4 Neoplasms 3 Prostatic Neoplasms, Castration-Resistant 2 Metastatic Castration-resistant Prostate Cancer 2 Metastatic Castration-Resistant Prostate Cancer 2 Salivary Glands Tumors 1 Prostate Cancer Metastatic 1 Pharmacogenetic Study 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Metastatic Hormone Refractory Prostate Cancer 1 Hyperaldosteronism 1 Castration-resistant Prostate Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Cancer 1

Interventions

Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01858441 2020-12-04

ABIGENE

Centre Antoine Lacassagne

Phase NA Completed

Pharmacogenetic Study

Data powered by HemOnc (CC BY 4.0) Colophon ⚡